GenDS

GenDS is a US-based commercialization consultancy specializing in accelerating growth for life science companies, particularly within the areas of gene therapy, molecular diagnostics, oncology, and rare diseases.

We provide a comprehensive suite of services, including market access strategy, licensing support, distribution network development, and regulatory affairs guidance. Our experienced international team helps companies navigate complex global markets and expand their reach effectively.

GenDS focuses on delivering measurable results for our clients, leveraging deep industry knowledge and a strategic approach to commercialization. We are dedicated to supporting companies in bringing innovative therapies to patients worldwide. We help companies in the healthcare sector achieve significant growth and market penetration.

Founded in 2022, GenDS has quickly established itself as a trusted partner for life science organizations seeking to expand their global footprint.